2Ondrey FG, Greig JR, Herscher L. Radiation dose to otologic structures during head and neck cancer radiation the rapy[J]. Laryngoscope,2000,110(2 Pt 1):217-221.
3Wang SZ, Chen ZC, McNamar JP, et al. The relationship between the protective effect of am ifostine and decreased in tereellular adhesion molecule 1 expression[J]. Am J Otolaryn gol Head Neck Med Surg,2005,26(2) :118-122.
5Ho W K, Wei W I, Yuen A P, et al. Otorrhea after grommet insertion for middle ear effusion in patients with nasopharyngeal carcinoma. Am J Otolaryngol, 1999,20:12-15.
6Young Y H, Lin K L,Ko J Y. Otitis media with effusion in patients with nasopharyngeal carcinoma postirradiation. Arch Otolaryngol Head Neck Surg, 1995, 121 :765-768.
7Young Y H, Lin K L,Ko J Y. Otitis media with effu sion in patients with nasopharyngeal carcinoma postirradiation. Arch Otolaryngol Head Neck Surg, 1995,121:765-768.
8Ho W K, Wei W I, Yuen A P,et al. Otorrhea after grommet insertion for middle ear effusion in patients with nasopharyngeal carcinoma. Am J Otolaryngol,1999,20:12-15.
9Skinner D W,Van Hasselt C A. A study of the complications of grommet tube insertion for secretory otitis media in the presence of nasopharyngeal carcinoma. Clin Otolaryngol Allied Sci, 1991,16:480- 482.
10Young H,Lin K L,Ko J Y. Otitis media with effusion in patients with nasopharyngeal carcinoma, postirradiation. Arch Otolaryngol Head Neck Surg, 1995, 121:765-768.
